SCHEMBL14929656

SCHEMBL14929656

c1ccc2c(c1)ncc1c2nc2ccccn21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 8/20 0.49
KDM4E B2RXH2 8/20 0.49
ALDH1A1 P00352 6/20 0.49
GLA P06280 6/20 0.49
GAA P10253 6/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
GABRA1 P14867 1/20 0.45
GABRG2 P18507 1/20 0.45
GABRB3 P28472 1/20 0.45
GABRA3 P34903 1/20 0.45
GABRA2 P47869 1/20 0.45
HPGD P15428 4/20 0.44
NPC1 O15118 3/20 0.44
POLB P06746 2/20 0.44
MEN1 O00255 2/20 0.44
RAB9A P51151 2/20 0.44
KMT2A Q03164 2/20 0.44
MAPT P10636 1/20 0.44
PARP1 P09874 1/20 0.43
HSD17B10 Q99714 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30966873 0.75 KDM4E (0.47) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL10062341 0.75 KDM4E (0.47) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL839837 0.71 ALDH1A1 (0.62) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL23533799 0.71 PARP1 (0.47) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL15641745 0.70 KDM4E (0.47) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL17620565 0.69 KDM4E (0.53) TLR7KDM4EALDH1A1GLAGAA
SCHEMBL14929655 0.69 GABRA1 (0.59) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL18807028 0.69 KDM4E (0.50) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL19314426 0.68 KDM4E (0.49) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL19314483 0.68 KDM4E (0.49) KDM4EALDH1A1GLAGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3165527-B1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO LTD (KR) 2019-06-26 EP disclosed
EP-3165527-B1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO LTD (KR) 2019-06-26 EP disclosed
US-10074811-B2 Compound and organic light emitting device comprising same SAMSUNG DISPLAY CO., LTD. (KR) 2018-09-11 US disclosed
EP-3165527-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME Samsung Display Co., Ltd. (KR) 2017-05-10 EP disclosed
EP-3165527-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME Samsung Display Co., Ltd. (KR) 2017-05-10 EP disclosed
US-20170125696-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-05-04 US disclosed
US-20170125696-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-05-04 US disclosed
US-9331290-B2 Metal complexes MERCK PATENT GMBH (DE) 2016-05-03 US disclosed
US-9331290-B2 Metal complexes MERCK PATENT GMBH (DE) 2016-05-03 US disclosed
US-20130112920-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
US-20130112920-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10074811-B2 Compound and organic light emitting device comprising same VDAC1, VDAC2, MCOLN2 TLR7 3326/4885KDM4E 2677/4885ALDH1A1 49/4885
US-20170125696-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME VDAC1, VDAC2, MCOLN2 TLR7 3326/4885KDM4E 2677/4885ALDH1A1 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.